CD8A and stroke disorder: IL-21 is known to regulate immune responses by promoting antibody production, T cell-mediated immunity, and NK cell and CD8+ T cell cytotoxicity; inhibiting IL-21 in experimental stroke correlated with improved behavioral outcome (Clarkson et al., 2014).